T0	Participants 38 63	metastatic breast cancer:
T1	Participants 170 332	67 patients with systemic breast cancer treated by chemotherapy; 55 were assessable by UICC criteria and the response index (96% of all UICC assessable patients).
T2	Participants 623 631	patients